KROS
NASDAQ · Biotechnology

Keros Therapeutics Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks
$10.96
-0.16 (-1.44%)
As of Mar 22, 10:20 PM ET ·
Analyst Consensus
Buy
15
Analysts
High
Coverage
Buy 10 67%
Hold 5 33%
Sell 0 0%
Price Target
Analyst Price Target +79.7% upside
Low Target $13.49
Average Target $19.70
High Target $20.36
Current Price $10.96
Current
$10.96
Target
$19.70
$13.49 $19.70 avg $20.36
Scenario Analysis
Bear Case
$13.49
23.1%
Low target
Base Case
$19.70
+79.7%
Avg target
Bull Case
$20.36
+85.8%
High target
Risk/Reward
3.7x
Highly favorable
Price in Context
52-Week High
$22.55
-51.4% from high
52-Week Low
$9.12
+20.2% from low
Target vs 52W High
$19.70
-12.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 39 69% $257.58 +24.3%
AMGN
Amgen Inc
 Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +162.3%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 -3.7%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -89.8%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
 Strong Buy 26 92% $143.40 -3.3%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -27.6%